Article info
PDFPostScript
Letter
Clarithromycin-containing triple therapy for Helicobacter pylori eradication is inducing increased long-term resistant bacteria communities in the gut
- Correspondence to Prof Mārcis Leja, University of Latvia Institute of Clinical and Preventive Medicine, Riga, LV-1079, Latvia; marcis.leja{at}lu.lv
Citation
Clarithromycin-containing triple therapy for Helicobacter pylori eradication is inducing increased long-term resistant bacteria communities in the gut
Publication history
- Received February 28, 2023
- Accepted June 12, 2023
- First published June 26, 2023.
Online issue publication
June 06, 2024
Article Versions
- Previous version (26 June 2023).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ.